Abstract
Suboptimal Humoral and Cellular Immune Response to SARS-CoV-2 RNA Vaccination in Myeloma Patients Is Associated with Anti-CD38 and BCMA-Targeted Treatment
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have